13F-HR filed by Opti Capital Management, LP
Opti Capital Management, LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 35 holding rows worth $1,065,646,000.
- Accession
- 0000919574-21-007036
- Filer
- CIK 1738654
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 35 entries on the cover page, a total value of $1,065,646,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,065,646,000 with VALUE read as thousands by filing date, 13F file number 028-19379. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC | 632307AB0 | BOND | 40,562,000 | $121,729,000 | thousands by filing date | principal |
| DICKS SPORTING GOODS INC | 253393AD4 | NOTE 3.250% 4/1 | 29,655,000 | $108,852,000 | thousands by filing date | principal |
| CONMED CORP | 207410AF8 | BOND | 45,565,000 | $70,876,000 | thousands by filing date | principal |
| NEW RELIC INC | 64829BAB6 | NOTE 0.500% 5/0 | 66,728,000 | $67,716,000 | thousands by filing date | principal |
| ON SEMICONDUCTOR CORP | 682189AP0 | NOTE 1.625%10/1 | 25,411,000 | $57,267,000 | thousands by filing date | principal |
| WORKIVA INC | 98139AAB1 | NOTE 1.125% 8/1 | 30,038,000 | $56,315,000 | thousands by filing date | principal |
| SUPERNUS PHARMACEUTICALS | 868459AD0 | BOND | 45,402,000 | $44,828,000 | thousands by filing date | principal |
| SAILPOINT TECHNOLOGIES HLDGS | 78781PAB1 | NOTE | 27,280,000 | $43,961,000 | thousands by filing date | principal |
| IONIS PHARMACEUTICALS INC | 462222AB6 | NOTE 0.125%12/1 | 38,938,000 | $35,848,000 | thousands by filing date | principal |
| VEECO INSTRS INC DEL | 922417AF7 | BOND | 18,500,000 | $32,937,000 | thousands by filing date | principal |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 29,150,000 | $32,235,000 | thousands by filing date | principal |
| FORTIVE CORP | 34959JAK4 | NOTE 0.875% 2/1 | 31,927,000 | $32,087,000 | thousands by filing date | principal |
| MANDIANT INC | 31816QAD3 | NOTE 1.625% 6/0 | 31,309,000 | $31,387,000 | thousands by filing date | principal |
| ALTERYX INC | 02156BAD5 | BOND | 31,867,000 | $30,273,000 | thousands by filing date | principal |
| INSIGHT ENTERPRISES INC | 45765UAB9 | NOTE 0.750% 2/1 | 20,836,000 | $29,250,000 | thousands by filing date | principal |
| REPLIGEN CORP | 759916AB5 | BOND | 10,534,000 | $26,675,000 | thousands by filing date | principal |
| KBR INC | 48242WAB2 | BOND | 16,000,000 | $25,747,000 | thousands by filing date | principal |
| VONAGE HLDGS CORP | 92886TAJ1 | NOTE 1.750% 6/0 | 20,880,000 | $24,518,000 | thousands by filing date | principal |
| FIVE9 INC | 338307AD3 | NOTE 0.500% 6/0 | 17,260,000 | $23,258,000 | thousands by filing date | principal |
| NUVASIVE INC | 670704AL9 | BOND | 22,410,000 | $22,927,000 | thousands by filing date | principal |
| BIOMARIN PHARMACEUTICAL INC | 09061GAH4 | NOTE 0.599% 8/0 | 17,461,000 | $18,030,000 | thousands by filing date | principal |
| MODEL N INC | 607525AB8 | NOTE 2.625% 6/0 | 12,000,000 | $15,195,000 | thousands by filing date | principal |
| Omeros Corp | 682143AE2 | NOTE 6.250%11/1 | 13,200,000 | $14,388,000 | thousands by filing date | principal |
| NATIONAL VISION HLDGS INC | 63845RAB3 | NOTE 2.500% 5/1 | 7,416,000 | $14,278,000 | thousands by filing date | principal |
| PEGASYSTEMS INC | 705573AB9 | NOTE 0.750% 3/0 | 11,500,000 | $13,045,000 | thousands by filing date | principal |
| FLEXION THERAPEUTICS INC | 33938JAB2 | NOTE | 13,158,000 | $11,742,000 | thousands by filing date | principal |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 14,960,000 | $11,437,000 | thousands by filing date | principal |
| RAMBUS INC DEL | 750917AG1 | NOTE 1.375% 2/0 | 7,000,000 | $8,868,000 | thousands by filing date | principal |
| LIGAND PHARMACEUTICALS INC | 53220KAF5 | NOTE 0.750% 5/1 | 8,722,000 | $8,782,000 | thousands by filing date | principal |
| PTC THERAPEUTICS INC | 69366JAB7 | NOTE | 8,000,000 | $8,383,000 | thousands by filing date | principal |
| IRONWOOD PHARMACEUTICALS INC | 46333XAF5 | BOND | 5,300,000 | $6,265,000 | thousands by filing date | principal |
| CSG SYS INTL INC | 126349AF6 | NOTE 4.250% 3/1 | 4,500,000 | $4,647,000 | thousands by filing date | principal |
| VIAVI SOLUTIONS INC | 925550AB1 | NOTE 1.000% 3/0 | 3,388,000 | $4,426,000 | thousands by filing date | principal |
| LENDINGTREE INC | 52603BAD9 | NOTE 0.500% 7/1 | 5,000,000 | $4,275,000 | thousands by filing date | principal |
| MANDIANT INC | 31816QAF8 | NOTE 0.875% 6/0 | 3,000,000 | $3,199,000 | thousands by filing date | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-21-007036 | this filing | 2021-11-15 | acceptance time not in the bulk data set |